Evidence map›Paper›PMID 29932318›Full record

ArticleACS chemical biology2018

Mitochondrial-Localized Versus Cytosolic Intracellular CO-Releasing Organic PhotoCORMs: Evaluation of CO Effects Using Bioenergetics.

Livia S Lazarus, Hector J Esquer, Stacey N Anderson, Lisa M Berreau, Abby D Benninghoff

Abstract read
In one paragraph

Article in ACS chemical biology, 2018. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 22 papers.

0numbers the graph read from it
0cells of the map it votes in
22citing papers in PubMed
2.5field-weighted citation impact, top 10% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

22 citing papers in PubMed, 45 citations in OpenAlex.

  1. Article
  2. Article
  3. Review
  4. Fluorescent small molecule donors.Chemical Society reviews · 2024
    Review
  5. Article
  6. Article
  7. Article
  8. "CO in a pill": Towards oral delivery of carbon monoxide for therapeutic applications.Journal of controlled release : official journal of the Controlled Release Society · 2021
    Review
  9. Review
  10. Article
  11. Article
  12. Towards "CO in a pill": Pharmacokinetic studies of carbon monoxide prodrugs in mice.Journal of controlled release : official journal of the Controlled Release Society · 2020
    Article
  13. Article
  14. Review
  15. Review
  16. Article
  17. Article
  18. Article
  19. Article
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors at 1 institution in 1 country.

Livia S LazarusDepartment of Chemistry and Biochemistry , Utah State University , Logan , Utah 84322-0300 , United States.ORCID 0000-0002-3001-3190
Hector J EsquerDepartment of Animal, Dairy and Veterinary Sciences , Utah State University , Logan , Utah 84322-4815 , United States.
Stacey N AndersonDepartment of Chemistry and Biochemistry , Utah State University , Logan , Utah 84322-0300 , United States.
Lisa M BerreauDepartment of Chemistry and Biochemistry , Utah State University , Logan , Utah 84322-0300 , United States.ORCID 0000-0001-9599-5239
Abby D BenninghoffDepartment of Animal, Dairy and Veterinary Sciences , Utah State University , Logan , Utah 84322-4815 , United States.
Utah State University · US

Funding

Chemical Tools for Delivery of Carbon MonoxideR15GM124596 · NIGMS · UTAH STATE UNIVERSITY · PI BERREAU, LISA M · 2017 to 2023
$861k
NIGMS NIH HHS R15 GM124596
6 · The paper itself

Abstract

While interactions between carbon monoxide (CO) and mitochondria have been previously studied, the methods used to deliver CO (gas or CO-releasing metal carbonyl compounds) lack subcellular targeting and/or controlled delivery. Thus, the effective concentration needed to produce changes in mitochondrial bioenergetics is yet to be fully defined. To evaluate the influence of mitochondrial-targeted versus intracellularly released CO on mitochondrial oxygen consumption rates, we developed and characterized flavonol-based CO donor compounds that differ at their site of release. These molecules are metal-free, visible light triggered CO donors (photoCORMs) that quantitatively release CO and are trackable in cells via confocal microscopy. Our studies indicate that at a concentration of 10 μM, the mitochondrial-localized and cytosolic CO-releasing compounds are similarly effective in terms of decreasing ATP production, maximal respiration, and the reserve capacity of A549 cells. This concentration is the lowest to impart changes in mitochondrial bioenergetics for any CO-releasing molecule (CORM) reported to date. The results reported herein demonstrate the feasibility of using a structurally tunable organic photoCORM framework for comparative intracellular studies of the biological effects of carbon monoxide.

Indexed as

A549 CellsAdenosine TriphosphateCarbon MonoxideCytosolEnergy MetabolismHumansMitochondriaOrganometallic CompoundsAdenosine TriphosphateCarbon MonoxideOrganometallic Compoundstricarbonylchloro(glycinato)ruthenium(II)tricarbonyldichlororuthenium (II) dimer

Identifiers

PMID29932318
PMCPMC6117112
OpenAlexW2808895619

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.